Viking Global Investors Lp |
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
1,388,889
|
$25,000,002 |
Viking Global Investors Lp |
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
1,388,889
|
$25,000,002 |
Viking Global Investors Lp |
Non-Executive |
Inhibrx, Inc. (INBX)
|
2023-08-28 |
$19.35 |
-17.1% |
511,627
|
$9,899,982 |
Viking Global Investors Lp |
Non-Executive |
4D Molecular Therapeutics, Inc. (FDMT)
|
2023-05-09 |
$16.00 |
-3.1% |
850,000
|
$13,600,000 |
Viking Global Investors Lp |
Non-Executive |
Inhibrx, Inc. (INBX)
|
2022-10-07 |
$30.00 |
-46.5% |
1,333,333
|
$39,999,857 |
Viking Global Investors Lp |
Non-Executive |
Amylyx Pharmaceuticals, Inc. (AMLX)
|
2022-01-11 |
$19.00 |
-88.4% |
2,300,000
|
$43,700,000 |
Viking Global Investors Lp |
Non-Executive |
PROCEPT BioRobotics Corp (PRCT)
|
2021-09-17 |
$35.00 |
118.1% |
400,000
|
$14,000,000 |
Viking Global Investors Lp |
Non-Executive |
Rallybio Corp (RLYB)
|
2021-07-29 |
$13.00 |
-91.5% |
806,000
|
$10,478,000 |
Viking Global Investors Lp |
Non-Executive |
4D Molecular Therapeutics Inc. (FDMT)
|
2020-12-15 |
$23.00 |
-32.6% |
1,100,000
|
$25,300,000 |
Viking Global Investors Lp |
Non-Executive |
Inhibrx, Inc. (INBX)
|
2020-08-26 |
$18.92 |
-15.2% |
180,219
|
$3,409,866 |
Viking Global Investors Lp |
Non-Executive |
Inhibrx, Inc. (INBX)
|
2020-08-25 |
$19.39 |
-17.3% |
131,465
|
$2,548,688 |
Viking Global Investors Lp |
Non-Executive |
Zentalis Pharmaceuticals, Inc. (ZNTL)
|
2020-04-07 |
$18.00 |
-82.0% |
725,000
|
$13,050,000 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
22.7% |
$51,277,687 |
$225,986,397 |